Safety, efficacy, and duration of effect of a new Botulinum Neurotoxin Type A preparation free of complexing proteins

被引：0
|
作者：
Wohlfarth, K
Mueller, C
机构：
来源：
MOVEMENT DISORDERS | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P35
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [41] Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX°) in healthy volunteers
    W. H. Jost
    A. Kohl
    S. Brinkmann
    G. Comes
    Journal of Neural Transmission, 2005, 112 : 905 - 913
  • [42] Efficacy and safety of NT 201 (Xeomin®, botulinum neurotoxin type A free from complexing proteins) for the treatment of blepharospasm: results of a double-blind, placebo-controlled, randomized, multi-center trial
    Jankovic, J.
    Comella, C.
    Hanschmann, A.
    Grafe, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S137 - S138
  • [43] INTERACTION OF TYPE-E BOTULINUM NEUROTOXIN WITH ITS COMPLEXING PROTEIN
    LAFONTAINE, C
    SINGH, BR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 36 - AGFD
  • [44] Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke
    Santamato, Andrea
    Panza, Francesco
    Ranieri, Maurizio
    Frisardi, Vincenza
    Micello, Maria Francesca
    Filoni, Serena
    Fortunato, Francesca
    Intiso, Domenico
    Basciani, Mario
    Logroscino, Giancarlo
    Fiore, Pietro
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (03) : 469 - 476
  • [45] Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia
    Comella, Cynthia L.
    Jankovic, Joseph
    Truong, Daniel D.
    Hanschmann, Angelika
    Grafe, Susanne
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 308 (1-2) : 103 - 109
  • [46] Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke
    Andrea Santamato
    Francesco Panza
    Maurizio Ranieri
    Vincenza Frisardi
    Maria Francesca Micello
    Serena Filoni
    Francesca Fortunato
    Domenico Intiso
    Mario Basciani
    Giancarlo Logroscino
    Pietro Fiore
    Journal of Neural Transmission, 2013, 120 : 469 - 476
  • [47] EFFECT OF UREA ON TYPE A BOTULINUM NEUROTOXIN
    UVAROVA, RN
    VINOGRADOVA, ID
    IVANOV, KK
    MOLECULAR BIOLOGY, 1983, 17 (02) : 228 - 233
  • [48] Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity
    Martin, Michael Uwe
    Frevert, Juergen
    Tay, Clifton Ming
    TOXINS, 2024, 16 (02)
  • [49] Use of an interactive voice response system by patients with blepharospasm receiving repeated injections of NT 201 (botulinum neurotoxin type A free from complexing proteins)
    Marx, M.
    Grafe, S.
    Jankovic, J.
    Comella, C.
    MOVEMENT DISORDERS, 2010, 25 (07) : S243 - S243
  • [50] Do Lower Doses of Botulinum Neurotoxin Type-A Offer a Longer Duration of Effect and Superior Efficacy in Patients with Cervical Dystonia?
    Kundrick, A.
    Fernandez, H.
    MOVEMENT DISORDERS, 2024, 39 : S644 - S644
12345